Results 241 to 250 of about 61,873 (295)
Some of the next articles are maybe not open access.
Journal of Neurology, 1995
Neuroleptic treatment frequently induces movement disorders, the tardive dyskinesias. These are frequently seen in the orobuccolingual region. Although the beginning of neuroleptic treatment can cause acute dystonia and breathing difficulty, chronic neuroleptic treatment has only rarely been shown to affect the laryngeal musculature. Laryngeal abnormal
A, Fève, B, Angelard, J, Lacau St Guily
openaire +2 more sources
Neuroleptic treatment frequently induces movement disorders, the tardive dyskinesias. These are frequently seen in the orobuccolingual region. Although the beginning of neuroleptic treatment can cause acute dystonia and breathing difficulty, chronic neuroleptic treatment has only rarely been shown to affect the laryngeal musculature. Laryngeal abnormal
A, Fève, B, Angelard, J, Lacau St Guily
openaire +2 more sources
American Journal of Psychiatry, 1981
The authors surveyed 500 inpatients receiving long-term neuroleptics; 8 had first-degree family members who were also being treated with long-term neuroleptics and suffering from a psychiatric disorder. The 8 patient-relative pairs showed concordance for the presence or absence of tardive dyskinesia.
R, Yassa, J, Ananth
openaire +2 more sources
The authors surveyed 500 inpatients receiving long-term neuroleptics; 8 had first-degree family members who were also being treated with long-term neuroleptics and suffering from a psychiatric disorder. The 8 patient-relative pairs showed concordance for the presence or absence of tardive dyskinesia.
R, Yassa, J, Ananth
openaire +2 more sources
Experimental tardive dyskinesia
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1982In this work, we have attempted to reproduce dyskinesia similar to tardive dyskinesia by two methods. In the first experiment, we have administered to 6 macaca mulatta, haloperidol 0.25 mg/kg daily for six months. During that period we observed in all monkeys, after each dose: restlessness, akinesia and tremor.
P J, Bédard, R, Boucher, L, Larochelle
openaire +2 more sources
Levetiracetam in Tardive Dyskinesia
Clinical Neuropharmacology, 2006The aim of this study was to evaluate the effect of levetiracetam on tardive dyskinesia (TD), which is known to be a major limitation of chronic antipsychotic drug therapy, particularly with conventional antipsychotics.Sixteen patients suffering from chronic psychosis with TD were enrolled consecutively.
MECO G +7 more
openaire +4 more sources
Minerva medica, 1985
Neuroleptic drug treatment can produce tardive dyskinesia of which the incidence, risk factors, clinical characteristics and problems of differential diagnosis are described. Possible therapeutic approaches are then considered in the light of the hypothesis that the condition may derive from a physiopathological hypersensitivity of the dopamine ...
SABBATINI F +4 more
openaire +4 more sources
Neuroleptic drug treatment can produce tardive dyskinesia of which the incidence, risk factors, clinical characteristics and problems of differential diagnosis are described. Possible therapeutic approaches are then considered in the light of the hypothesis that the condition may derive from a physiopathological hypersensitivity of the dopamine ...
SABBATINI F +4 more
openaire +4 more sources
Experimental Tardive Dyskinesia
1985In ongoing studies of chronic administration of neuroleptics to monkeys (Cebus apella) and rats, the regional distribution of glutamic acid decarboxylase (GAD) and brain levels of homovanillic acid were examined. Reduction of GAD activity, a GABA-synthesizing enzyme, in three specific brain areas (substantia nigra, medial globus pallidus, and nucleus ...
L M, Gunne, J E, Häggström
openaire +2 more sources
American Journal of Psychiatry, 1975
The author reports an atypical case of tardive dyskinesia in a 19-year-old male who had been given relatively low dosages of neuroleptic medication for less than 6 months. The symptoms cleared within 3 months after the medication was discontinued. The author reviews the literature regarding similar atypical cases and suggests that increased reporting ...
openaire +2 more sources
The author reports an atypical case of tardive dyskinesia in a 19-year-old male who had been given relatively low dosages of neuroleptic medication for less than 6 months. The symptoms cleared within 3 months after the medication was discontinued. The author reviews the literature regarding similar atypical cases and suggests that increased reporting ...
openaire +2 more sources
Tardive Dyskinesia: Treatment Update
Current Neurology and Neuroscience Reports, 2019D. Arya +3 more
semanticscholar +1 more source